What is the price target for IGC stock?
5 analysts have analysed IGC and the average price target is 3.7 USD. This implies a price increase of 1311.26% is expected in the next year compared to the current price of 0.262.
IGC PHARMA INC (IGC) Forecast, Price Target & Analyst Ratings
NYSEARCA:IGC • US45408X3089
Current stock price
0.262 USD
+0.01 (+3.56%)
At close:
0.2678 USD
+0.01 (+2.21%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for IGC PHARMA INC (IGC).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Jun 25, 2026
- Period
- Q3 / 2026
- EPS Estimate
- -$0.02
- Revenue Estimate
- 328.25K
Price Target Details & History
Consensus Price Target and Range
Mean target
$3.70
Upside
+ 1,311.26%
From current price of $0.26 to mean target of $3.70, Based on 5 analyst forecasts
Low
$3.03
Median
$3.70
High
$4.46
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
5 Wall Street analysts provided a forecast for the next 12 months for IGC. The average price target is 3.7 USD. This implies a price increase of 1311.26% is expected in the next year compared to the current price of 0.262.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
80.00%
IGC was analyzed by 5 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about IGC.
In the previous month the buy percentage consensus was at a similar level.
Only 5 analysts analyzed IGC. So this is just the average opinion of a couple of analysts.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-23 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-12-09 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-08-26 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-03-06 | Alliance Global Partners | Reiterate | Buy -> Buy |
| 2025-02-24 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2024-12-05 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2024-09-03 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2024-07-29 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2024-07-17 | Alliance Global Partners | Initiate | Buy |
| 2024-06-21 | Ascendiant Capital | Reiterate | Buy -> Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Jun 25, 2026
- Period
- Q3 / 2026
- EPS Estimate
- -$0.02
- Revenue Estimate
- 328.25K
- Revenue Q2Q
- 27.72%
- EPS Q2Q
- 7.71%
- Number of Analysts
- 2
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
-36.38%
EPS (3 Months)
-36.38%
Next Earnings Summary
IGC is expected to report earnings on 6/25/2026. The consensus EPS estimate for the next earnings is -0.02 USD and the consensus revenue estimate is 328.25K USD.
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
Full Analyst Estimates 2026 - 2027
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 910K 127.50% | 1.345M 47.80% | 1.271M -5.50% | 1.316M 3.54% | 1.515M 15.12% | |
| EBITDA YoY % growth | -10.53M -4.99% | -8.161M 22.50% | -6.611M 18.99% | N/A | N/A | |
| EBIT YoY % growth | -11.19M -4.78% | -8.798M 21.38% | -7.229M 17.83% | -7.976M -10.33% | -9.373M -17.51% | |
| Operating Margin | -1,229.67% | -654.13% | -568.76% | -606.08% | -618.67% | |
| EPS YoY % growth | N/A | N/A | -0.08 62.20% | -0.07 12.09% | -0.07 10.64% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.02 7.71% | -0.01 -46.65% | -0.01 26.67% | -0.01 9.70% | -0.02 0.68% | -0.02 -50.00% |
| Revenue Q2Q % growth | 328.25K 27.72% | 328.25K -0.53% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -2.017M -10.22% | -2.017M -62.01% | N/A | N/A | N/A | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
IGC PHARMA INC / IGC Forecast FAQ
When does IGC PHARMA INC (IGC) report earnings?
IGC PHARMA INC (IGC) will report earnings on 2026-06-25.
What are the consensus estimates for IGC PHARMA INC (IGC) next earnings?
The consensus EPS estimate for the next earnings of IGC PHARMA INC (IGC) is -0.02 USD and the consensus revenue estimate is 328.25K USD.